List of Tables
Table 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competitive Situation by Manufacturers in 2022
Table 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Benign Prostatic Hyperplasia (BPH) Treatment Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Benign Prostatic Hyperplasia (BPH) Treatment Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Benign Prostatic Hyperplasia (BPH) Treatment Devices, Product Type & Application
Table 12. Global Key Manufacturers of Benign Prostatic Hyperplasia (BPH) Treatment Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2018-2023) & (K Units)
Table 18. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2018-2023)
Table 19. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2024-2029) & (K Units)
Table 20. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2024-2029)
Table 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2018-2023)
Table 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2024-2029)
Table 25. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 27. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2024-2029) & (K Units)
Table 28. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 32. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2024-2029) & (K Units)
Table 33. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2018-2023)
Table 51. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2024-2029)
Table 52. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2018-2023)
Table 53. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2024-2029)
Table 54. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2018-2023)
Table 57. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2024-2029)
Table 58. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Type (2018-2023)
Table 59. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Type (2024-2029)
Table 60. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2018-2023)
Table 61. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2024-2029)
Table 62. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2018-2023)
Table 63. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2024-2029)
Table 64. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2018-2023)
Table 67. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2024-2029)
Table 68. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Application (2018-2023)
Table 69. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Application (2024-2029)
Table 70. Advin Urology Corporation Information
Table 71. Advin Urology Description and Business Overview
Table 72. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 74. Advin Urology Recent Developments/Updates
Table 75. Biolitec Corporation Information
Table 76. Biolitec Description and Business Overview
Table 77. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 79. Biolitec Recent Developments/Updates
Table 80. Boston Scientific Corporation Corporation Information
Table 81. Boston Scientific Corporation Description and Business Overview
Table 82. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 84. Boston Scientific Corporation Recent Developments/Updates
Table 85. CONMED Corporation Information
Table 86. CONMED Description and Business Overview
Table 87. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 89. CONMED Recent Developments/Updates
Table 90. Convergent Laser Technologies Corporation Information
Table 91. Convergent Laser Technologies Description and Business Overview
Table 92. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 94. Convergent Laser Technologies Recent Developments/Updates
Table 95. CoreTherm Medical, Inc. (ProstaLund) Corporation Information
Table 96. CoreTherm Medical, Inc. (ProstaLund) Description and Business Overview
Table 97. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 99. CoreTherm Medical, Inc. (ProstaLund) Recent Developments/Updates
Table 100. HistoSonics, Inc. Corporation Information
Table 101. HistoSonics, Inc. Description and Business Overview
Table 102. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 104. HistoSonics, Inc. Recent Developments/Updates
Table 105. JenaSurgical GmbH Corporation Information
Table 106. JenaSurgical GmbH Description and Business Overview
Table 107. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 109. JenaSurgical GmbH Recent Developments/Updates
Table 110. KARL STORZ Corporation Information
Table 111. KARL STORZ Description and Business Overview
Table 112. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 114. KARL STORZ Recent Developments/Updates
Table 115. LISA Laser Products GmbH Corporation Information
Table 116. LISA Laser Products GmbH Description and Business Overview
Table 117. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 119. LISA Laser Products GmbH Recent Developments/Updates
Table 120. Lumenis Ltd. Corporation Information
Table 121. Lumenis Ltd. Description and Business Overview
Table 122. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 124. Lumenis Ltd. Recent Developments/Updates
Table 125. Medifocus, Inc. Corporation Information
Table 126. Medifocus, Inc. Description and Business Overview
Table 127. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 129. Medifocus, Inc. Recent Developments/Updates
Table 130. Endo International Corporation Information
Table 131. Endo International Description and Business Overview
Table 132. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 134. Endo International Recent Developments/Updates
Table 135. Medtronic Corporation Information
Table 136. Medtronic Description and Business Overview
Table 137. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 139. Medtronic Recent Developments/Updates
Table 140. Siemens Corporation Information
Table 141. Siemens Description and Business Overview
Table 142. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 144. Siemens Recent Developments/Updates
Table 145. Olympus Corporation Information
Table 146. Olympus Description and Business Overview
Table 147. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 149. Olympus Recent Developments/Updates
Table 150. Urologix Corporation Information
Table 151. Urologix Description and Business Overview
Table 152. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 154. Urologix Recent Developments/Updates
Table 155. NeoTract Corporation Information
Table 156. NeoTract Description and Business Overview
Table 157. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 159. NeoTract Recent Developments/Updates
Table 160. Urotech Corporation Information
Table 161. Urotech Description and Business Overview
Table 162. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 164. Urotech Recent Developments/Updates
Table 165. Baxter International Corporation Information
Table 166. Baxter International Description and Business Overview
Table 167. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product
Table 169. Baxter International Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
Table 173. Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers List
Table 174. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends
Table 175. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Drivers
Table 176. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Challenges
Table 177. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Type in 2022 & 2029
Figure 4. Surgical Treatment Product Picture
Figure 5. Minimally Invasive Treatment Product Picture
Figure 6. Laser Treatment Product Picture
Figure 7. Other Product Picture
Figure 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application in 2022 & 2029
Figure 10. Fertility Clinics
Figure 11. Hospitals
Figure 12. Others
Figure 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (2018-2029) & (US$ Million)
Figure 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (2018-2029) & (K Units)
Figure 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (US$/Unit) & (2018-2029)
Figure 17. Benign Prostatic Hyperplasia (BPH) Treatment Devices Report Years Considered
Figure 18. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers in 2022
Figure 19. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Benign Prostatic Hyperplasia (BPH) Treatment Devices Players: Market Share by Revenue in 2022
Figure 21. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2018-2029)
Figure 24. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2018-2029)
Figure 28. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2018-2029)
Figure 29. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2018-2029)
Figure 36. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2018-2029)
Figure 47. Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2018-2029)
Figure 57. Global Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2018-2029)
Figure 58. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2018-2029)
Figure 60. Global Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application (2018-2029)
Figure 61. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Application (2018-2029)
Figure 62. Benign Prostatic Hyperplasia (BPH) Treatment Devices Value Chain
Figure 63. Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
